Global HIV, Hepatitis and STIs Programmes
The Department of Global HIV, Hepatitis and Sexually Transmitted Infections Programmes leads the development and implementation of the global health sector strategy on the elimination of the diseases as public health threats.

HIV guidelines

Latest guidelines

WHO guideline on contact tracing
This practical guideline establishes definitions for “contact”, “contact person”, “contact tracing” and other associated concepts. It allows for improvement...
Guidelines for HIV post-exposure prophylaxis

Despite advancements in testing and treatment, over one million people became infected with HIV in 2022. This warrants a need for a revitalized focus on...

More HIV guidelines

WHO guideline on contact tracing

This practical guideline establishes definitions for “contact”, “contact person”, “contact tracing” and other associated...

Guidelines for HIV post-exposure prophylaxis

Despite advancements in testing and treatment, over one million people became infected with HIV in 2022. This warrants a need for a revitalized focus on...

Consolidated guidelines on differentiated HIV testing services

These guidelines outline a public health approach to strengthening and expanding HIV testing services (HTS). They present and discuss key updates to...

Updated recommendations for the treatment of Neisseria gonorrhoeae, Chlamydia trachomatis, and Treponema pallidum (‎syphilis)‎ and new recommendations on syphilis testing and partner services

The objectives of these present guidelines are: to provide updated evidence-informed guidance on treating infections caused by N. gonorrhoeae and C. trachomatis...

Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations

The Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations outline a public health response...

Consolidated guidelines on person-centred HIV strategic information: strengthening routine data for impact

As the HIV response moves to focusing on closing the remaining gaps in prevention, testing and treatment services, an evolution in the underlying routine...

Guidelines on long-acting injectable cabotegravir for HIV prevention

In this guideline, WHO recommends that long-acting injectable cabotegravir (CAB-LA) may be offered as an additional HIV prevention option for people...

WHO preferred 
product 
characteristics 
for monoclonal 
antibodies for 
HIV prevention

It is a priority for WHO to ensure that products are developed in a manner that supports optimal use globally, including in low- and middle-income countries...

Guidelines for diagnosing, preventing and managing cryptococcal disease among adults, adolescents and children living with HIV

Cryptococcal disease is one of the most common opportunistic infections among people living with advanced HIV disease and is a major contributor to severe...